US EditionPublished • loading... • Updated
Truist Financial Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Summary by defenseworld.net
1 Articles
1 Articles
Truist Financial Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective raised by Truist Financial from $140.00 to $145.00 in a research report released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on GILD. Mizuho lifted their price target on Gilead Sciences from $131.00 to $140.00 and gave the stock an “outperform” rating in a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
